Location: Home
  • search
  • go
  • Relate News
  • 8/14/2018Chinese Pharmacopoeia Commission Announces Proposed Addition of 40 Bio...
  • 8/14/2018Shanghai Regulator: Speaking Fees to Physicians Constitute Bribery
  • 8/14/2018IQVIA: Peeking Into China's Healthcare Deals
  • 8/14/2018State Council Issues Notice to Divide Fiscal Responsibilities of Centr...
  • 8/14/2018SCMP: Fierce Competition in China's Nascent Immuno-therapy Cancer Drug...
  • 8/14/2018EU: Zhejiang Tianyu the Second Chinese Producer of Tainted Heart Drug
  • 8/14/2018China National Drug Administration Sets Guidelines for Overseas Drug T...
  • 8/14/2018Big Pharma Opportunities Aplenty in China
  • 8/14/2018Sihuan Pharma's Self-Developed Anticancer Pirotinib Commenced Phase II...
  • 8/14/2018India's Pharmexcil to sign MoU with China Trade Body for Expedite Drug...
  • 8/13/2018Haisco and Pneuma Enter Equity Investment and China Distribution Deal
  • 8/13/2018SMEI: Chinese Drug Terminal Market Up 6.9% in H1
  • 8/12/2018Sanpower Sell Dendreon to Affiliate Nanjing Cenbest for $820M
  • 8/10/2018Recent Executive Moves
  • 8/9/2018Cross-Border Funding in the Life Sciences
  • 8/9/2018Review of Chinese Pharma Deals, R&D and Regulatory Developments in...
  • 8/9/2018CDE Publicizes Batch 31 of Drug Applications To Be Granted Priority Re...
  • 8/9/2018SMIA Official: BMI Negotiation for 18 Anticancers To Be Concluded by S...
  • 8/9/2018China Approves Amgen's Anti-cholesterol Drug Repatha
  • 8/9/2018Pfizer's Breast Cancer Drug Ibrance Receives Approval in China
  • 8/9/2018BeiGene Drops 5% on Hong Kong IPO Debut
  • 8/9/2018EdiGene Raises $15M Pre-Series B Led by Lilly Asia Ventures
  • 8/9/2018Harbour BioMed and Glenmark Pharma Sign Agreement for Greater China to...
  • 8/8/2018CDE Solicits Comments on List of Urgently-needed New Drugs Marketed Ov...
  • 8/8/2018CBT Pharma Gets Ethics Approval for APOLLO-1 Phase 1/2 Trial for Hepat...
  • 8/8/2018IQVIA: Overview of the Chinese Pharmaceutical Market in 2017
  • 8/8/2018Novartis Voluntarily Withdraws Zemeta for Injection in China, Followin...
  • 8/8/2018Novartis China Reorganizes to Better Position for New Business
  • 8/7/2018CNDA Approves Gilead's HIV Drug Genvoya
  • 8/7/2018MorphoSys and I-Mab Announce China IND Submission of mAb for MM
  • Page:313/774 Total number of articles:23207: [First][<<] [311] [312] [313] [314] [315] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group